- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 42 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.4: 2 residues within 4Å:- Chain A: Q.22, N.55
Ligand excluded by PLIPNAG.5: 3 residues within 4Å:- Chain A: N.1070, T.1072, F.1075
Ligand excluded by PLIPNAG.6: 3 residues within 4Å:- Chain A: N.99, E.121, F.147
Ligand excluded by PLIPNAG.7: 2 residues within 4Å:- Chain A: N.109, T.111
Ligand excluded by PLIPNAG.8: 1 residues within 4Å:- Chain A: N.148
Ligand excluded by PLIPNAG.9: 3 residues within 4Å:- Chain A: E.258, N.259
- Chain C: R.534
Ligand excluded by PLIPNAG.10: 2 residues within 4Å:- Chain A: N.308, K.556
Ligand excluded by PLIPNAG.11: 3 residues within 4Å:- Chain A: N.347
- Chain C: Y.432, Y.465
Ligand excluded by PLIPNAG.12: 1 residues within 4Å:- Chain A: N.592
Ligand excluded by PLIPNAG.13: 2 residues within 4Å:- Chain A: N.681, G.1103
Ligand excluded by PLIPNAG.14: 3 residues within 4Å:- Chain A: N.689, Q.894, Q.1043
Ligand excluded by PLIPNAG.15: 4 residues within 4Å:- Chain A: Y.768, N.773, S.775, Q.776
Ligand excluded by PLIPNAG.16: 2 residues within 4Å:- Chain A: N.1046
- Chain B: Q.867
Ligand excluded by PLIPNAG.18: 1 residues within 4Å:- Chain A: N.1106
Ligand excluded by PLIPNAG.20: 2 residues within 4Å:- Chain B: Q.22, N.55
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain B: N.1070, T.1072, F.1075
Ligand excluded by PLIPNAG.22: 3 residues within 4Å:- Chain B: N.99, E.121, F.147
Ligand excluded by PLIPNAG.23: 2 residues within 4Å:- Chain B: N.109, T.111
Ligand excluded by PLIPNAG.24: 1 residues within 4Å:- Chain B: N.148
Ligand excluded by PLIPNAG.25: 3 residues within 4Å:- Chain A: R.534
- Chain B: E.258, N.259
Ligand excluded by PLIPNAG.26: 2 residues within 4Å:- Chain B: N.308, K.556
Ligand excluded by PLIPNAG.27: 3 residues within 4Å:- Chain A: Y.432, Y.465
- Chain B: N.347
Ligand excluded by PLIPNAG.28: 1 residues within 4Å:- Chain B: N.592
Ligand excluded by PLIPNAG.29: 2 residues within 4Å:- Chain B: N.681, G.1103
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain B: N.689, Q.894, Q.1043
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain B: Y.768, N.773, S.775, Q.776
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain B: N.1046
- Chain C: Q.867
Ligand excluded by PLIPNAG.34: 1 residues within 4Å:- Chain B: N.1106
Ligand excluded by PLIPNAG.37: 2 residues within 4Å:- Chain C: Q.22, N.55
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain C: N.1070, T.1072, F.1075
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain C: N.99, E.121, F.147
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain C: N.109, T.111
Ligand excluded by PLIPNAG.41: 2 residues within 4Å:- Chain B: Y.328
- Chain C: N.148
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain B: R.534
- Chain C: E.258, N.259
Ligand excluded by PLIPNAG.43: 2 residues within 4Å:- Chain C: N.308, K.556
Ligand excluded by PLIPNAG.44: 3 residues within 4Å:- Chain B: Y.432, Y.465
- Chain C: N.347
Ligand excluded by PLIPNAG.45: 1 residues within 4Å:- Chain C: N.592
Ligand excluded by PLIPNAG.46: 2 residues within 4Å:- Chain C: N.681, G.1103
Ligand excluded by PLIPNAG.47: 3 residues within 4Å:- Chain C: N.689, Q.894, Q.1043
Ligand excluded by PLIPNAG.48: 4 residues within 4Å:- Chain C: Y.768, N.773, S.775, Q.776
Ligand excluded by PLIPNAG.49: 2 residues within 4Å:- Chain A: Q.867
- Chain C: N.1046
Ligand excluded by PLIPNAG.51: 1 residues within 4Å:- Chain C: N.1106
Ligand excluded by PLIP- 3 x BLA: BILIVERDINE IX ALPHA(Non-covalent)
BLA.17: 15 residues within 4Å:- Chain A: E.83, N.86, V.88, R.89, G.90, W.91, I.106, I.107, N.108, V.113, R.173, F.175, K.188, I.209, F.210
12 PLIP interactions:12 interactions with chain A- Hydrophobic interactions: A:N.86, A:V.88, A:W.91, A:I.106, A:N.108, A:V.113, A:K.188, A:I.209, A:F.210
- Hydrogen bonds: A:N.108, A:R.173
- pi-Cation interactions: A:R.173
BLA.33: 15 residues within 4Å:- Chain B: E.83, N.86, V.88, R.89, G.90, W.91, I.106, I.107, N.108, V.113, R.173, F.175, K.188, I.209, F.210
12 PLIP interactions:12 interactions with chain B- Hydrophobic interactions: B:N.86, B:V.88, B:W.91, B:I.106, B:N.108, B:V.113, B:K.188, B:I.209, B:F.210
- Hydrogen bonds: B:N.108, B:R.173
- pi-Cation interactions: B:R.173
BLA.50: 15 residues within 4Å:- Chain C: E.83, N.86, V.88, R.89, G.90, W.91, I.106, I.107, N.108, V.113, R.173, F.175, K.188, I.209, F.210
12 PLIP interactions:12 interactions with chain C- Hydrophobic interactions: C:N.86, C:V.88, C:W.91, C:I.106, C:N.108, C:V.113, C:K.188, C:I.209, C:F.210
- Hydrogen bonds: C:N.108, C:R.173
- pi-Cation interactions: C:R.173
- 3 x EIC: LINOLEIC ACID(Non-covalent)
EIC.19: 13 residues within 4Å:- Chain A: R.385, T.392, G.393, V.394
- Chain B: C.313, I.335, A.340, Y.342, Y.346, F.351, F.354, F.369, L.489
8 PLIP interactions:2 interactions with chain A, 6 interactions with chain B- Hydrogen bonds: A:V.394
- Salt bridges: A:R.385
- Hydrophobic interactions: B:I.335, B:Y.342, B:Y.342, B:Y.346, B:F.369, B:L.489
EIC.35: 13 residues within 4Å:- Chain B: R.385, T.392, G.393, V.394
- Chain C: C.313, I.335, A.340, Y.342, Y.346, F.351, F.354, F.369, L.489
8 PLIP interactions:6 interactions with chain C, 2 interactions with chain B- Hydrophobic interactions: C:I.335, C:Y.342, C:Y.342, C:Y.346, C:F.369, C:L.489
- Hydrogen bonds: B:V.394
- Salt bridges: B:R.385
EIC.36: 13 residues within 4Å:- Chain A: C.313, I.335, A.340, Y.342, Y.346, F.351, F.354, F.369, L.489
- Chain C: R.385, T.392, G.393, V.394
9 PLIP interactions:3 interactions with chain C, 6 interactions with chain A- Hydrogen bonds: C:Q.386, C:V.394
- Salt bridges: C:R.385
- Hydrophobic interactions: A:I.335, A:Y.342, A:Y.342, A:Y.346, A:F.369, A:L.489
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, X. et al., Disulfide stabilization reveals conserved dynamic features between SARS-CoV-1 and SARS-CoV-2 spikes. Life Sci Alliance (2023)
- Release Date
- 2022-10-19
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-trimer
- Ligands
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 42 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 3 x BLA: BILIVERDINE IX ALPHA(Non-covalent)
- 3 x EIC: LINOLEIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhang, X. et al., Disulfide stabilization reveals conserved dynamic features between SARS-CoV-1 and SARS-CoV-2 spikes. Life Sci Alliance (2023)
- Release Date
- 2022-10-19
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C